Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 77, Issue 3, 2002, Pages 463-467

  Dulitzky, Mordechai ^a   Cohen, Shlomo B ^a   Inbal, Aida ^a   Seidman, Daniel S ^a   Soriano, Daniel ^a   Lidor, Arieh ^a   Mashiach, Shlomo ^a   Rabinovici, Jaron ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Ovarian hyperstimulation syndrome; Ovulation induction; Thromboembolism; Thrombophilia

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; PROTEIN C; PROTEIN S;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; MAJOR CLINICAL STUDY; OVARY DISEASE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREVALENCE; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOPHILIA;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTITHROMBIN III; DNA; FACTOR V; FEMALE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN S; THROMBOPHILIA;

EID: 0036183395     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)03218-6     Document Type: Article

References (25)

1. Ovarian hyperstimulation syndrome; a current survey
2. Prevention and treatment of ovarian
3. Ovarian hyperstimulation syndrome and thrombosis. Apropos of a case of thrombosis of the internal jugular vein
4. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism
5. Ovarian hyperstimulation syndrome; prediction by number and size of preovulatory ovarian follicles
6. Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate; menotropin therapy for induction of ovulation
7. Inherited thrombophilia; part 1
8. Inherited thrombophilia; pathogenesis, clinical syndromes, and management
9. The antiphospholipid syndrome; ten years on
10. Antiphospholipid-thrombosis syndromes
11. Internal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in-vitro fertilization
12. Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in vitro fertilization
13. Detection and quantitative evaluation of lupus circulating anticoagulant activity
14. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism
15. A candidate genetic risk factor for vascular disease; a common mutation in methylenetetrahydrofolate reductase
16. Familial protein S deficiency is associated with recurrent thrombosis
17. Protein S levels during the normal menstrual cycle and during estrogen therapy for premature ovarian failure
18. Thrombophilia and lipid profile in post-menopausal women using a new transdermal oestradiol patch
19. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium
20. The Writing Group for the Estradiol Clotting Factors Study. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate; a 1-year, double-blind, placebo-controlled study
21. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis
22. Comparison of protein S functional and antigenic assays in normal pregnancy
23. Thrombophilia as a multigenic disorder
24. Increased fetal loss in women with heritable thrombophilia
25. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis